IRulya Leadership Monday, October 19, 2026 +0.20 Positive

IRulya Therapeutics Updates Investors with Corporate Presentation

IRulya Therapeutics, formerly Quince Therapeutics, released an October 2026 corporate presentation to update stakeholders on the status of its product candidates and business strategy.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed